Switch to:

Corcept Therapeutics Days Sales Outstanding

: 25.08 (As of Sep. 2019)
View and export this data going back to 2004. Start your Free Trial

Corcept Therapeutics's Accounts Receivable for the three months ended in Sep. 2019 was $22.4 Mil. Corcept Therapeutics's Revenue for the three months ended in Sep. 2019 was $81.5 Mil. Hence, Corcept Therapeutics's days sales outstanding for the three months ended in Sep. 2019 was 25.08.

NAS:CORT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.55   Max: 61.48
Current: 28.65
25.55
61.48

During the past 13 years, Corcept Therapeutics's highest Days Sales Outstanding was 61.48. The lowest was 25.55. And the median was 45.16.

NAS:CORT's Days Sales Outstanding is ranked higher than
82% of the 701 Companies
in the Biotechnology industry.

( Industry Median: 67.85 vs. NAS:CORT: 28.65 )

Corcept Therapeutics's days sales outstanding declined from Sep. 2018 (27.41) to Sep. 2019 (25.08).

Corcept Therapeutics Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.83 45.16 44.26 35.08 25.55

Corcept Therapeutics Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.41 24.01 27.05 24.97 25.08
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Corcept Therapeutics Days Sales Outstanding Distribution

* The bar in red indicates where Corcept Therapeutics's Days Sales Outstanding falls into.


Corcept Therapeutics Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Corcept Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2018 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=17.588/251.247*365
=25.55

Corcept Therapeutics's Days Sales Outstanding for the quarter that ended in Sep. 2019 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=22.405/81.505*365 / 4
=25.08

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Corcept Therapeutics  (NAS:CORT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Corcept Therapeutics Days Sales Outstanding Related Terms

Corcept Therapeutics Days Sales Outstanding Headlines

From the Internet

CORT
Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y

- Zacks 2020-02-21 13:25:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */